Skip to main content
. Author manuscript; available in PMC: 2016 Oct 25.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2013;53:557–580. doi: 10.1146/annurev-pharmtox-010510-100456

Table 3.

Binding affinity assays and biological assays for design of nonpeptide opioid receptor-selective ligands based on TMT1-DPDPE

Compound Binding affinity assays Biological assays
vs[3H]pCl-DPDPE IC50 (nM) vs[3H]DAMGO IC50 (nM) MVD EC50 (nM) GPI EC50 (nM)
[2S,3R]TMT1-DPDPE 5.0 4,300 1.8 antagonist
I A; R = H 6,400 8,100
I B; R = Me 610 780
I C; R = i-Bu 420 2,100
I D; R = C6H3 34 500 174 1,250
I E; R = p-tBu-C6H4 8.4 17,000 85 39,000
I E (+); R = p-tBu-C6H4 42 11,000 210 3,000
I E (−); R = p-tBu-C6H4 41 7,700 360 7,600
[MeO-Tyr1]DPDPE 230 11,000
II; m-CH3O,
 R = p-tBu-C6H4
1,800 >8,000
DPDPE 1.6 610 4.1 7,300

Abbreviations: DAMGO, [D-Ala2,N-MePhe4,Gly-ol]enkephalin; DPDPE, c[D-Pen2,D-Pen5]enkephalin; GPI, guinea pig ileum; MVD, mouse vas deferens; ND, not determined; TMT, β-methyl-2′,6′-dimethyltyrosine (trimethyltyrosine).